Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Tetraphase receives FDA guidance on eravacycline program

May 13, 2016

Vaccitech launched from Oxford Sciences

May 13, 2016

CIADM begins advanced development of anthrax vaccine

May 12, 2016

Novel pGX2303 vaccine provides full protection against RSV in animal model

May 12, 2016

Phase I/II results for novel maternal trivalent GBS vaccine

May 12, 2016

US Phytotherapy conducting preclinical studies of PROACT-Z for Zika infection

May 11, 2016

Janssen plans phase IIb study of AL-335, odalasvir and simeprevir combinations for chronic HCV

May 11, 2016

VBI Vaccines and SciVac Therapeutics complete merger

May 10, 2016

CSIR discloses antimalaria compounds

May 10, 2016

Takeda partners with Gates Foundation on polio vaccine for developing countries

May 9, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...